Open AccessEfficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
Author(s) -
Richard W Simpson,
Geoffrey C. Nicholson,
Joseph Proietto,
Alana Sarah,
Kerrie M. Sanders,
G. Phillips,
J D Chambers,
Rob MacGinley,
Neil Orford,
Ken Walder,
Guy Y. Krippner,
Kathy Skoff,
Vincent J. Wacher
Publication year - 2014
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc14-1038
Subject(s) - medicine , placebo , metformin , type 2 diabetes , diabetes mellitus , clinical endpoint , gastroenterology , endocrinology , surgery , randomized controlled trial , pathology , alternative medicine
To evaluate the safety and efficacy of methazolamide as a potential therapy for type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom